CARL ZEISS MEDITEC ADR 1 (AFXA) — Net Asset Quality Index
CARL ZEISS MEDITEC ADR 1 (AFXA) has a Net Asset Quality Index of 62.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €3.40 Billion minus total liabilities of €1.28 Billion yields net assets of €2.13 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check AFXA asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
CARL ZEISS MEDITEC ADR 1 Net Asset Quality Index Over Time (2022–2025)
This chart shows how CARL ZEISS MEDITEC ADR 1's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of September 2025, the index stands at 62.5%, representing net assets of €2.13 Billion against total assets of €3.40 Billion EUR. See working capital position of CARL ZEISS MEDITEC ADR 1 to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for CARL ZEISS MEDITEC ADR 1 (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for CARL ZEISS MEDITEC ADR 1 from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CARL ZEISS MEDITEC ADR 1 market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 62.5% | €2.13 Billion | €3.40 Billion | €1.28 Billion | ▲ +1.9 pp |
| 2024 | 60.6% | €2.06 Billion | €3.39 Billion | €1.34 Billion | ▼ -11.0 pp |
| 2023 | 71.6% | €2.17 Billion | €3.03 Billion | €860.02 Million | ▼ -0.3 pp |
| 2022 | 71.9% | €2.03 Billion | €2.82 Billion | €792.73 Million | — |